Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca L Swan

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Molecular Pharmacology|May 4, 2021
A Role for VCP/p97 in the Processing of Drug-Stabilized TOP2-DNA Covalent ComplexesRebecca L Swan, Ian G Cowell, Caroline A Austin
Molecular Pharmacology|October 24, 2021
Mechanisms to Repair Stalled Topoisomerase II-DNA Covalent ComplexesRebecca L Swan, Ian G Cowell, Caroline A Austin
Molecular Pharmacology|June 27, 2020
Small Molecule Inhibitors Confirm Ubiquitin-Dependent Removal of TOP2-DNA Covalent ComplexesRebecca L Swan, Luke L K Poh, Ian G Cowell, et al.
Case Reports in Ophthalmological Medicine|February 20, 2025
A Case of Sarcoid Uveitis Diagnosed With Mammography Two Months After Normal Chest ImagingMadison Riccardi, Robert Contento, Cory Christensen, et al.
Chest|July 25, 2013
A rare case of empyema. Answer: Transformation of CLL into diffuse large B-cell lymphoma, also known as Richter syndromeNeil M Yager, Ketan Ghate, Rebecca L Swan, et al.
International Journal of Molecular Sciences|July 18, 2018
Effect of TDP2 on the Level of TOP2-DNA Complexes and SUMOylated TOP2-DNA ComplexesKa Cheong Lee, Rebecca L Swan, Zbyslaw Sondka, et al.
Molecular Pharmacology|September 14, 2019
The Deubiquitinating Enzyme Inhibitor PR-619 is a Potent DNA Topoisomerase II PoisonIan G Cowell, Elise M Ling, Rebecca L Swan, et al.
Molecular Pharmacology|August 11, 2019
Intercalating TOP2 Poisons Attenuate Topoisomerase Action at Higher ConcentrationsMandeep Atwal, Rebecca L Swan, Chloe Rowe, et al.
International Journal of Molecular Sciences|September 19, 2018
TOP2B: The First Thirty YearsCaroline A Austin, Ka C Lee, Rebecca L Swan, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular Pharmacology|May 4, 2021
A Role for VCP/p97 in the Processing of Drug-Stabilized TOP2-DNA Covalent ComplexesRebecca L Swan, Ian G Cowell, Caroline A Austin
Molecular Pharmacology|October 24, 2021
Mechanisms to Repair Stalled Topoisomerase II-DNA Covalent ComplexesRebecca L Swan, Ian G Cowell, Caroline A Austin
Molecular Pharmacology|June 27, 2020
Small Molecule Inhibitors Confirm Ubiquitin-Dependent Removal of TOP2-DNA Covalent ComplexesRebecca L Swan, Luke L K Poh, Ian G Cowell, et al.
Case Reports in Ophthalmological Medicine|February 20, 2025
A Case of Sarcoid Uveitis Diagnosed With Mammography Two Months After Normal Chest ImagingMadison Riccardi, Robert Contento, Cory Christensen, et al.
Chest|July 25, 2013
A rare case of empyema. Answer: Transformation of CLL into diffuse large B-cell lymphoma, also known as Richter syndromeNeil M Yager, Ketan Ghate, Rebecca L Swan, et al.
International Journal of Molecular Sciences|July 18, 2018
Effect of TDP2 on the Level of TOP2-DNA Complexes and SUMOylated TOP2-DNA ComplexesKa Cheong Lee, Rebecca L Swan, Zbyslaw Sondka, et al.
Molecular Pharmacology|September 14, 2019
The Deubiquitinating Enzyme Inhibitor PR-619 is a Potent DNA Topoisomerase II PoisonIan G Cowell, Elise M Ling, Rebecca L Swan, et al.
Molecular Pharmacology|August 11, 2019
Intercalating TOP2 Poisons Attenuate Topoisomerase Action at Higher ConcentrationsMandeep Atwal, Rebecca L Swan, Chloe Rowe, et al.
International Journal of Molecular Sciences|September 19, 2018
TOP2B: The First Thirty YearsCaroline A Austin, Ka C Lee, Rebecca L Swan, et al.
Pageof 1